Merck No Longer in Talks to Buy Revolution Medicines

The drugmaker had recently been in discussions to acquire RevMed in a deal that could have valued the cancer-drug biotech at around $30 billion.


http://dlvr.it/TQYbBX

Comments

Popular posts from this blog

The best Bluetooth trackers for 2026

Productivity Tips for Busy People: Proven Hacks to Maximize Efficiency

Financial Stability for 2026